Departments & Organizations
Specialized Center of Research (SCOR) to Develop Gender-Sensitive Treatment for Tobacco Dependence
Global Health Initiative: Social & Behavioral Health
Dr Bhagwagar trained in medicine and psychiatry at Delhi University India and subsequently retrained in psychiatry at the University of Oxford, United Kingdom where he obtained membership of the Royal College of Psychiatrists. He has been at Yale University since 2005 and has a specific interest in the clinical application of state of the art neuroimaging paradigms to understand the neurobiology of recurrent depression. Paradigms used include positron emission tomography, magnetic resonance spectroscopy and fMRI.
Since 2009 Dr Bhagwagar has been working in the pharmaceutical industry first at Bristol-Myers Squibb and is currently at Alexion Pharmaceuticals in New Haven.
Education & Training
|PhD||University of Oxford (2004)|
|MD||Maulana Azad Medical College (1994)|
|MBBS||Maulana Azad Medical College (1989)|
|Medical Research Council Clinical Training Fellow||Medical School, University Of Oxford|
|Clinical Research Fellow||Institute of Psychiatry, King's College London|
|Resident||University of Oxford|
|Resident||University of Delhi|
Depression, UK United Kingdom (2010)
A Study of GABA And 5-HT Interactions to Test a Molecular Model of Vulnerability